Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
Ciclosporin
Novartis Ireland Limited
L04AD; L04AD01
Ciclosporin
100 milligram(s)/millilitre
Concentrate for oral solution
Product subject to prescription which may be renewed (B)
Calcineurin inhibitors; ciclosporin
Marketed
1995-10-16
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT NEORAL ® 100 MG/ML CONCENTRATE FOR ORAL SOLUTION ciclosporin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See Section 4. WHAT IS IN THIS LEAFLET 1. What Neoral is and what it is used for 2. What you need to know before you take Neoral 3. How to take Neoral 4. Possible side effects 5. How to store Neoral 6. Contents of the pack and other information 1. WHAT NEORAL IS AND WHAT IT IS USED FOR WHAT NEORAL IS The name of your medicine is Neoral. It contains the active substance ciclosporin. This belongs to a group of medicines known as immunosuppressive agents. These medicines are used to lower the body’s immune reactions. WHAT NEORAL IS USED FOR AND HOW NEORAL WORKS • IF YOU HAVE HAD AN ORGAN TRANSPLANT, BONE MARROW AND STEM CELL TRANSPLANTATION , the function of Neoral is to control your body’s immune system. Neoral prevents rejection of transplanted organs by blocking the development of certain cells which would normally attack the transplanted tissue. • IF YOU HAVE AN AUTOIMMUNE DISEASE , in which your body’s immune response attacks your body’s own cells, Neoral stops this immune reaction. Such diseases include eye problems which threaten your vision (endogenous uveitis, including Behçet's uveitis), severe cases of certain skin diseases (atopic dermatitis, or eczema and psoriasis), severe rheumatoid arthritis and a kidney disease called nephrotic syndrome. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NEORAL If you are taking Neoral following a transplant it will only be prescribed fo Lue koko asiakirja
Health Products Regulatory Authority 04 July 2023 CRN00DPGN Page 1 of 21 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Neoral 100 mg/ml concentrate for oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of concentrate for oral solution contains 100 mg ciclosporin. Excipients with known effect: Ethanol: 94.70 mg/ml. Neoral oral solution contains 12% v/v ethanol (9.5% m/v). Propylene glycol: 94.70 mg/ml. Macrogolglycerol hydroxystearate/Polyoxyl 40 hydrogenated castor oil: 383.70 mg/ml. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Concentrate for oral solution. Clear, faintly yellow to brownish yellow solution. The formulation of Neoral is a microemulsion preconcentrate. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Transplantation indications _Solid organ transplantation_ Prevention of graft rejection following solid organ transplantation. Treatment of transplant cellular rejection in patients previously receiving other immunosuppressive agents. _Bone marrow transplantation_ Prevention of graft rejection following allogeneic bone marrow and stem cell transplantation. Prevention or treatment of graft-versus-host disease (GVHD). Non-transplantation indications _Endogenous uveitis_ Treatment of sight-threatening intermediate or posterior uveitis of non-infectious aetiology in patients in whom conventional therapy has failed or caused unacceptable side effects. Treatment of Behçet uveitis with repeated inflammatory attacks involving the retina in patients without neurological manifestations. _Nephrotic syndrome_ Steroid-dependent and steroid-resistant nephrotic syndrome, due to primary glomerular diseases such as minimal change nephropathy, focal and segmental glomerulosclerosis, or membranous glomerulonephritis. Neoral can be used to induce and maintain remissions. It can also be used to maintain steroid-induced remission, allowing withdrawal of steroids. _Rheumatoid arthritis_ Treatment of severe, active rheumatoid arthritis. Health Products Regulatory Lue koko asiakirja